GET THE APP

A DFT study of the inhibition of human phosphodiesterases PDE3A and PDE3B by a group of 2-(4-(1H-tetrazol-5-yl)-1H-pyrazol-1-yl)-4-(4-phenyl)thiazole derivatives | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

A DFT study of the inhibition of human phosphodiesterases PDE3A and PDE3B by a group of 2-(4-(1H-tetrazol-5-yl)-1H-pyrazol-1-yl)-4-(4-phenyl)thiazole derivatives

Author(s): Juan S. Gómez-Jeria and Patricio Cornejo-Martínez

Here we present the results of the investigation of the relationships between electronic structure and human phosphodiesterases PDE3A and PDE3B inhibition by a group of 2-(4-(1H-tetrazol-5-yl)-1H-pyrazol-1-yl)-4-(4- phenyl)thiazole derivatives. The electronic structure was obtained with Density Functional Theory at the B3LYP/6- 31G(d,p) level after full geometry optimization. Statistically significant equations were obtained for both systems. Both inhibitory processes are orbital-controlled. The associated pharmacophores may provide information for possible modifications of the common skeleton


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry